We are committed to rigorous science and innovative drug development, and we are excited to share our ongoing progress.
Showing 7 out of 7
Clermont A, Murugesan N, Feener EP
ARVO 2024
Clermont AC, Murugesan N, Edwards HJ, Lee DK, Bayliss NP, Duckworth EJ, Pethen SJ, Hampton SL, Gailani D, Feener EP
Clermont A, Pinckney F, Hill M, Hampton SL, Feener EP
Allen C Clermont, Daniel Lee, Nivetha Murugesan, Hannah J Edwards, Stephen J Pethen, Edward J Duckworth, Sally L HamptonĀ and Edward P Feener
Clermont AC, Murugesan N, Feener EP
Murugesan N, Lee DK, Duckworth EJ, Smith SA, Clermont AC, Hampton SL, Feener EP
Clermont AC, Murugesan N, Edwards HJ, Whitney SA, Pethen SJ, Duckworth EJ, Hampton SL, Feener EP